Xiangling Ren, Meijia Liu, Ming Tang, Longfei Tan, Changhui Fu, Qiong Wu, Hongbo Li, Yi Chen, Lufeng Chen, Xianwei Meng
Journal: Journal of biomedical nanotechnology 2021;17(9):1806-1811
PMID: 34688325
Lactate dehydrogenase (LDH) is one of key enzymes in glucose metabolism pathway, which plays a critical role in cell metabolism. Inhibition of LDH can inhibit glycolysis process, thereby inhibiting the occurrence and development of tumor cells. Two kinds of LDH inhibitors, apigenin and emodin, were obtained by testing the IC of several natural products in LDH enzyme reaction. The IC of apigenin was about 1/3 of LDH inhibitor sodium oxalate. A new method to evaluate the performance of LDH inhibitors based on CdTe QDs was established at the same time, which provides a new idea for research on LDH enzyme inhibitors.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.